AxoGen Past Earnings Performance
Past criteria checks 0/6
AxoGen has been growing earnings at an average annual rate of 2.3%, while the Medical Equipment industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 10.6% per year.
Key information
2.3%
Earnings growth rate
4.5%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 10.6% |
| Return on equity | -22.8% |
| Net Margin | -13.0% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How AxoGen makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 164 | -21 | 121 | 29 |
| 31 Dec 23 | 159 | -22 | 121 | 28 |
| 30 Sep 23 | 152 | -23 | 120 | 28 |
| 30 Jun 23 | 148 | -23 | 118 | 28 |
| 31 Mar 23 | 144 | -25 | 117 | 28 |
| 31 Dec 22 | 139 | -29 | 117 | 27 |
| 30 Sep 22 | 134 | -29 | 113 | 27 |
| 30 Jun 22 | 128 | -32 | 111 | 26 |
| 31 Mar 22 | 127 | -32 | 110 | 25 |
| 31 Dec 21 | 127 | -27 | 106 | 24 |
| 30 Sep 21 | 128 | -28 | 108 | 23 |
| 30 Jun 21 | 131 | -22 | 106 | 21 |
| 31 Mar 21 | 119 | -22 | 99 | 19 |
| 31 Dec 20 | 112 | -24 | 96 | 18 |
| 30 Sep 20 | 108 | -25 | 94 | 18 |
| 30 Jun 20 | 103 | -29 | 95 | 18 |
| 31 Mar 20 | 108 | -28 | 100 | 18 |
| 31 Dec 19 | 107 | -29 | 103 | 18 |
| 30 Sep 19 | 102 | -27 | 97 | 16 |
| 30 Jun 19 | 96 | -26 | 92 | 16 |
| 31 Mar 19 | 90 | -26 | 87 | 14 |
| 31 Dec 18 | 84 | -22 | 80 | 12 |
| 30 Sep 18 | 77 | -20 | 72 | 10 |
| 30 Jun 18 | 71 | -18 | 65 | 8 |
| 31 Mar 18 | 65 | -12 | 58 | 7 |
| 31 Dec 17 | 60 | -10 | 52 | 7 |
| 30 Sep 17 | 55 | -14 | 49 | 6 |
| 30 Jun 17 | 50 | -14 | 46 | 5 |
| 31 Mar 17 | 45 | -14 | 42 | 5 |
| 31 Dec 16 | 41 | -14 | 39 | 4 |
| 30 Sep 16 | 38 | -12 | 36 | 4 |
| 30 Jun 16 | 34 | -13 | 34 | 4 |
| 31 Mar 16 | 30 | -13 | 31 | 4 |
| 31 Dec 15 | 27 | -13 | 29 | 3 |
| 30 Sep 15 | 24 | -16 | 26 | 3 |
| 30 Jun 15 | 21 | -16 | 23 | 3 |
| 31 Mar 15 | 19 | -17 | 21 | 3 |
| 31 Dec 14 | 17 | -18 | 20 | 3 |
| 30 Sep 14 | 15 | -15 | 19 | 3 |
| 30 Jun 14 | 13 | -16 | 18 | 3 |
| 31 Mar 14 | 12 | -15 | 17 | 3 |
| 31 Dec 13 | 11 | -15 | 16 | 2 |
| 30 Sep 13 | 10 | -14 | 15 | 2 |
| 30 Jun 13 | 9 | -13 | 14 | 2 |
Quality Earnings: LT3 is currently unprofitable.
Growing Profit Margin: LT3 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: LT3 is unprofitable, but has reduced losses over the past 5 years at a rate of 2.3% per year.
Accelerating Growth: Unable to compare LT3's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: LT3 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-9.8%).
Return on Equity
High ROE: LT3 has a negative Return on Equity (-22.84%), as it is currently unprofitable.